Evidence map›Paper›PMID 22394568›Full record

ArticleEpidemiology and infection2013

ST22 and ST239 MRSA duopoly in Singaporean hospitals: 2006-2010.

J Teo, T Y Tan, P Y Hon, W Lee, T H Koh, P Krishnan, L Y Hsu, Network for Antimicrobial Resistance Surveillance (Singapore)

Abstract read
In one paragraph

Article in Epidemiology and infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Nasal Methicillin-ResistantOpen forum infectious diseases · 2021
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. MRSA Transmission Dynamics Among Interconnected Acute, Intermediate-Term, and Long-Term Healthcare Facilities in Singapore.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J TeoDepartment of Pharmacy, Singapore General Hospital, Singapore.
T Y Tan
P Y Hon
W Lee
T H Koh
P Krishnan
L Y Hsu
Network for Antimicrobial Resistance Surveillance (Singapore)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surveillance is integral for the monitoring and control of infectious diseases. We conducted prospective laboratory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) in five Singaporean public-sector hospitals from 2006 to 2010, using WHONET 5.6 for data compilation and analysis. Molecular profiling using multilocus variable-number tandem-repeat analysis, staphylococcal cassette chromosome mec classification and multilocus sequence typing was performed for a random selection of isolates. Our results showed overall stable rates of infection and bacteraemia, although there was significant variance among the individual hospitals, with MRSA rates increasing in two smaller hospitals and showing a trend towards decreasing in the two largest hospitals. The proportion of blood isolates that are EMRSA-15 (ST22-IV) continued to increase over time, slowly replacing the multi-resistant ST239-III. A new MRSA clone - ST45-IV - is now responsible for a small subset of hospital infections locally. More effort is required in Singaporean hospitals in order to reduce the rates of MRSA infection significantly.

Indexed as

Molecular TypingCluster AnalysisDNA, BacterialDrug Resistance, Multiple, BacterialGenotypeHospitalsHumansMethicillin-Resistant Staphylococcus aureusMolecular EpidemiologySingaporeStaphylococcal InfectionsDNA, Bacterial

Identifiers

PMID22394568
PMCPMC9152064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.